Stanford professor James Zou examined the clinical adoption of medical AI devices, and found that only a handful are being ...

Advances in technology, particularly generative AI and at-home diagnostics, have turned the once-distant idea of consumerism ...

The inspection closed with 10 observations. The observations are of procedural in nature and will be responded to within the stipulated time.

A new approach to cancer treatment became available shortly before Jimmy Carter needed it. Now it's a pillar of care.

Aurobindo Pharma's subsidiary Apitoria Pharma has received 10 observations from the USFDA for its API manufacturing facility ...

Last week, brokerage firm UBS Securities also initiated a 'sell' call on Aurobindo Pharma, assigning it a price target of Rs 1,333, predicting a 12 percent downside.